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Abstract
Background & objectives: The involvement of private drug vendors in malaria treatment is
particularly high in developing countries and understanding their practices and knowledge about
antimalarials and malaria treatment will aid in devising strategies to increase the correct use of
antimalarials and improve adherence to the government’s malaria drug policy. Results of a study on
the knowledge and practices of the private drug vendors conducted in seven districts in Sri Lanka,
mostly in malarious areas are presented.
Methods: Data on awareness of government’s malaria drug policy, practice of issuing antimalarials,
knowledge about malaria and antimalarial drugs were collected from the drug vendors using pre-
tested questionnaire in vernacular language. Data were statistically analysed using Stata 8.2. Chi-
square test was carried out for individual explanatory variables and a logistic regression model was
applied taking all response variables as binary outcome.
Results: Vendors’ knowledge on antimalarials was poor with 58% of the vendors being unaware of
the government malaria drug policy in the country. Also, the advice provided to customers buying
antimalarials was limited. However, the majority of the private vendors emphasised that they were
aware of the importance of case confirmation before treatment as stressed in the national policy.
Although, the vendors did not have a high awareness of national drug policies they were only found
selling chloroquine and primaquine as recommended by the Ministry of Health.
Interpretation & conclusion: In recent years Sri Lanka, as a whole, has experienced very little
malaria. The reduction in demand for antimalarials due to low incidence levels may have influenced
the knowledge and awareness on antimalarials and government drug policies. However, since low
levels of malaria do not guarantee that epidemics will not occur, attempts to educate private drug
vendors as a part of an organised control programmes are of major importance.
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Introduction
Widespread use of antimalarial drugs for all types
of fever and non-compliance with recommended
dosage contribute markedly to drug resistance and
necessitate continual change in malaria treatment
guidelines. Preserving the efficacy of the antimalarial
drugs in use is of critical importance to public healthRAJAKARUNA et al : MALARIA TREATMENT IN SRI LANKA 59
in malaria endemic areas. In support of this the
WHO1 has recognised that monitoring and influe-
ncing the quality of private services are key
components of effective malaria treatment. The
involvement of private drug vendors in malaria
treatment is particularly high in developing countries
but maintaining the quality of the service and
monitoring compliance with national malaria
treatment guidelines is difficult2.
In Sri Lanka, microscopically confirmed blood
smears or rapid diagnostic kits are standard dia-
gnostic procedures adopted before the prescription
of malaria drugs to patients. The first line of drugs
recommended is chloroquine (CQ) and primaquine
(PQ) combination for Plasmodium vivax and P.
falciparum infections. So far, there have been no
reports of CQ-resistant P. vivax infections in Sri
Lanka but a significant number of CQ resistant cases
of P. falciparum have been recorded from various
endemic areas3–6. For CQ resistant cases of P. falci-
parum the government recommended drug is
sulphadoxine-pyrimethamine (SP), which is admini-
stered as an out-patient treatment only by government
hospitals. The first SP resistant P. falciparum case
was reported in 1992 from the Polonnaruwa district7,
and later in other areas of the Northern Province8,9.
Quinine is recommended for SP resistant cases as an
in-patient treatment at government hospitals.
In most of the malaria endemic areas of Sri Lanka,
the services at the government health facilities with
qualified staff are free. Patients and families visit
government hospitals for malaria treatment where
high preference is given to blood slide confirmation
prior to the initiation of treatment10. However, limi-
ted information is available on treatment seeking
behaviour in the northern and certain areas in the
eastern part of the country due to the armed conflict
in the region. But a study indicates that people in
these areas also seek care relatively fast and initial
treatment with paracetamol to reduce fever is as
common as in the rest of the country11. One major
disadvantage at government facilities is that patients
often have to be in queues before seeing a doctor,
especially during the high transmission seasons12.
This has paved the way for a large number of private
practitioners and drug outlets to provide treatment
sometimes with laboratory facilities for diagnosis.
The private facility as a treatment provider has a high
acceptance among part of the community based on
the perception that the treatment seeking requires less
time and the attention given is more thorough12.
Private or government drug outlets are permitted by
law not to issue any antimalarial drugs without a
prescription or a confirmed blood slide (Cosmetic
Devices and Drug Act (1979). In recognition of the
practice of direct treatment-seeking at pharmacies
for prescription drugs in Sri Lanka, it is important to
assess the knowledge and drug dispensing practices
of private vendors. Other malaria endemic countries
have shown that the level of technical knowledge of
private drug vendors is low2,13. Here, we present
results of a survey on the therapeutic knowledge of
malaria and awareness of the treatment policy and
practices of private drug vendors in selected endemic
districts in Sri Lanka. Understanding the practices
of those who sell antimalarial drugs, their knowledge
about the antimalarials and malaria treatment will
aid in devising strategies to increase the appropriate
use of antimalarials and enable the designing of
programmes to improve on the services of the private
drug vendor. This will in turn constrain the spread
of antimalarial drug resistance in the country.
Methodology
Study area: This study was conducted among phar-
macies located in seven districts of Sri Lanka—
Anuradhapura, Ampara, Vavuniya, Mannar,
Moneragala, Hambantota and Badulla over a period
of three months from November 2004 to February
2005. The transmission levels of malaria within the
selected districts vary slightly with parasite
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ranging from 0.025–0.8 (Table 1). In Badulla district
the incidences are much lower with less than 0.025
per 1,000 population and this district is not consi-
dered as a malaria endemic district (Table 1). How-
ever, patients from neighbouring districts with
comparatively high malaria incidences are known
to visit hospitals and pharmacies in the Badulla
district.
Data collection: All drug outlets in small towns
were visited and, in large cities, outlets were
randomly selected (every other outlet along a
market street). These outlets were categorised as
pharmacies selling only drugs or a drug outlet found
within a grocery/general store. The responding sales
person was defined as the drug vendor who was
present at the time of the visit and was responsible
for issuing drugs. A verbal consent was sought
before the interview. After explaining the objectives
of the study, structured interviews were conducted
with each drug vendor in the vernacular (Sinhala
or Tamil with a translator), using a pre-tested
questionnaire. Information about the drug vendor
(age, sex, educational background and training of
the respondent), drug outlet (age, registration status,
distance to the closest government health facility,
antimalarials available etc.), and antimalarial drugs
(price, expiry date, storage practices) and the types
and frequency of interactions with the government
health care services were collected. For some of
this information an observation checklist was
applied and filled out immediately after leaving the
drug outlet.
Specific questions were asked from the vendor to
assess his/her knowledge about antimalarial drugs,
awareness of the importance of case confirmation
before issuing drugs, awareness of the government
malaria drug policy and whether the vendors provide
sufficient advice to the customers after dispensing
drugs. An interview lasted 20–60 min depending on
the number of customers visiting the shop during
the interview. By combining several questions four
aggregate variables were generated.
(a) Knowledge of the antimalarial drugs: The
vendors were asked eight questions including, ability
to identify antimalarials, ability to identify SP
derivatives, knowledge of adult and child doses of
CQ and PQ (e.g. 10 tablets of CQ per adult), ability
to mention at least one side effect of the drug CQ
and PQ, storage practices (drugs stored away from
sun and dust regarded as good storage). One point
was assigned to each correct answer and a zero for
incorrect or ‘don’t know’ answer. If a vendor scored
more than 50% (i.e. 4 or more correct answers) he/
she was considered as having sufficient knowledge
about antimalarials drugs.
Table 1. Population, number of government health care facilities and malaria incidence in the seven surveyed districts
District Population Government health care facilities Malaria incidence*
in 2001 GH BH DH PU RH CD Total Pf Pv
Anuradhapura 746,466 1 2 5 5 33 14 60 0.025–0.5 0.2–0.4
Ampara 589,344 1 2 1 1 3 17 25 0.2–0.4 0.4–0.8
Vavuniya 149,835 1 – 1 1 4 2 09 0.025–0.05 0.05–0.1
Mannar 151,577 1 – 2 1 2 5 11 0.2–0.4 0.1–0.2
Moneragala 396,173 – 1 9 1 7 9 17 0.025–0.05 0.2–0.4
Hambantota 525,370 1 3 3 4 7 8 26 0–0.025 0.05–0.1
Badulla 774,555 1 2 11 1 13 6 34 0–0.025 0.025–0.05
GH = General hospital; BH = Base hospital; DH = District hospital; PU = Peripheral unit; RH = Rural hospital; CD = Central
dispensary; *Parasite incidence per 1,000 population14.RAJAKARUNA et al : MALARIA TREATMENT IN SRI LANKA 61
(b) Awareness of case confirmation before issuing
drugs: This was assessed by the awareness of the
vendor recommending the customer to consult a
doctor or a blood test prior to issuing of antimalarials.
Vendors were asked what general practice they
followed when patients asked for antimalarials
without producing a prescription or a positive blood
slide confirmation. If the vendor claimed that he/she
either recommended a blood test or consulting a
doctor before issuing antimalarials, he/she was
considered as having sufficient awareness of the
importance of case confirmation before issuing
antimalarials.
(c) Awareness of a government malaria drug policy:
Four questions, including knowledge of the existence
of a policy and ability to mention first, second and
third lines of drugs respectively, were asked to assess
awareness. If a vendor scored more than 50% (i.e.
2 or more correct answers) he/she was considered
being sufficiently aware of the government malaria
drug policy.
(d) Providing sufficient advice to customers buying
antimalarials: Six questions on knowledge about
recommended adult and child dosages of CQ and
PQ (e.g. 4+4+2 tablets for three consecutive days in
case of CQ for adults), advising the patient to
complete the dose and instructing the patient to see
a doctor if symptoms persist, were asked. If a vendor
scored more than three of the six questions asked
he/she was considered as providing sufficient advice
to the customers after issuing antimalarials.
Data analysis: Twelve explanatory variables were
included in the analysis to explain differences found
in the four aggregated response variables. These
included sex, age, formal training, educational level,
his/her position in the shop, and the type of city where
the outlet was located, type of shop, distance to the
nearest government health facility, age of the outlet,
availability and sources of antimalarials and whether
the pharmacy was registered or not. Statistical
analysis was conducted using Stata 8.2. Chi-square
test was carried out for individual explanatory
variables and a logistic regression model was applied
taking all response variables as binary outcome. A
comparison on vendors from high and low
transmission areas and also of conflict affected and
non-affected areas was carried out. The results of
the logistic regression analysis were reported as odds
ratios (OR) together with their 95% confidence
intervals (CI).
Results
Profile of the vendors: Majority of the vendors (67%)
in the 113 drug outlets interviewed were males. More
than half of the vendors were between the age of 18
and 30 years (53%) with very few (2%) being under
the age of 18. Most of the vendors (56%) had
secondary education and above, with 11% having
completed only primary education or less. Only 31%
of the vendors were qualified pharmacists and the
rest were employed either as sales persons, cashiers,
owner or the wife of the owner of the outlet. Of the
all the vendors interviewed, only 9% of them had
undergone formal training on malaria, malaria
treatment and antimalarial drugs.
Profile of the drug outlet: A high percentage of the
outlets examined (91%) were registered and the
certificate of registration was displayed. All drug
outlets were located in urban areas either in big cities
(district capitals, 36%) or small towns (64%) and no
private vendors were found in rural areas in the seven
districts studied. Except for two outlets, all others
were clustered within a kilometer of a government
health facility. The period of existence of the outlets
could be categorised into three groups with 18%
having existed for less than one year; 31% between
one and five years; and the balance 51% for more
than five years. Eighteen percent of the outlets visited
were pharmacies selling only drugs. However, the
majority of the outlets (82%) were either in a grocery
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were not sold in all the outlets despite the fact that
these were malaria endemic regions, having only
57% of the outlets surveyed selling antimalarials.
None of the outlets displayed posters about
antimalarials or carried any other information about
the disease.
Drugs available and prices: The main provider of
the drugs was the State Pharmaceutical Corporation
(SPC; 56%); a few retailers (5%) obtained drugs
directly from drug companies in India. However,
39% of the respondents claimed that they were
unaware of the source of drugs mainly because they
purchased their goods from drug companies through
sales representatives. The drug outlets had CQ and
PQ in stock and only one outlet in Vavuniya district
sold the S/P drug Fansidar®. The prices of drugs
varied slightly in the seven districts but the average
price per tablet of CQ, PQ and Fansidar® were SLR
0.40–1.60, 0.80–3.75 and 15 respectively. None of
the antimalarials sold was past the expiry date
indicated on the container. According to vendors,
consumer misuse of antimalarials was primarily to
provoke abortions by intake of high doses in the first
trimester.
Knowledge of the antimalarial drugs: Out of the 113
only 37 (33%) vendors were able to score 50% or
more in the eight questions regarding knowledge of
antimalarial drugs. Even though 72 (64%) and 42
(37%) vendors were able to tell the correct adult
dosage for CQ and PQ respectively, only 3% of them
were able to tell the correct child dosage relating it
to the age and/or weight of the child. A logistical
regression analysis was performed to identify
variables explaining differences in vendors’
knowledge of antimalarial drugs controlling for the
influence of confounders after adjusting for all the
confounding factors (distance to the government
hospital, sources of antimalarials). Vendors older than
30 years of age (OR 2.26; CI 0.89–5.7) and males
more than females (OR 2.76; CI 0.94–8.07) seemed
to have a better knowledge of antimalarials although
this was not significant. Vendors in outlets older than
one year significantly had a better knowledge of
antimalarial drugs than those at outlets that were less
than 1 year in existence (OR 4.86; CI 1.21–19.52).
Not surprisingly, it was also found that vendors in
outlets having antimalarials had a significantly better
knowledge than the vendors in outlets where
antimalarials were unavailable (OR 3.24; CI 1.22–
8.57).
Awareness of case confirmation before issuing drugs:
The majority (83%) of the vendors interviewed
claimed that they requested their customers to see a
doctor or have a blood test done before issuing
antimalarials. However, some vendors (12%) said
that they would issue antimalarial drugs, without case
confirmation, if the patient was a regular customer
or a friend. Generally, the statements by the vendors
indicated that they followed the government
recommendations of not selling antimalarials unless
a confirmation had been established by a qualified
health professional. In drug outlets where
antimalarials were available, the respondents were
more aware of this government policy as compared
to respondents in outlets where antimalarials were
unavailable (OR 9.01; 95% CI 2.2–36.4). None of
the other explanatory variables included in the
analysis could explain differences in awareness of
the case confirmation including differences in
transmission levels.
Awareness of the government malaria drug policy:
More than half of the vendors (58%) surveyed could
not provide any information on the malaria treatment
policy indicating that they did not know the existence
of such a policy for Sri Lanka and out of the 113
outlets only one vendor from Hambantota district
was able to list all three lines of drugs correctly.
Results from a logistic regression analysis (after
controlling for confounding) showed that age of the
vendor (> 30 years; OR 4.59; CI 1.78–11.2) had a
significant effect on the awareness of the existence
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other parameters could significantly explain diffe-
rences of the vendors’ awareness of the government
malaria drug policy.
Providing sufficient advice to the customers buying
antimalarials: It was found that many vendors (68%)
provided inadequate advice to customers buying
antimalarials, especially the importance of
completing the dose and to see a doctor if symptoms
persisted. Some vendors (18%) considered that
providing advice was the duty of the doctor. A
logistical analysis showed that education of the
respondent (OR 3.04; CI 1.02–11.10) and the
availability of the antimalarial drugs in the drug outlet
(OR 3.69; CI 1.23–11.10) were the only parameters
that influenced the ability of the vendor proving
sufficient advice to the patient after issuing drugs.
No significant differences in the four aggregate
variables assessing the knowledge and/or practices
of the private vendors in the different areas
considering low and high transmission areas and
conflict affected vs nonconflict affected areas, were
observed.
Discussion
Although this study shows that the private drug
vendors lacked awareness of the overall malaria
treatment guidelines of Sri Lanka they almost
exclusively sell the government established first line
antimalarial drugs. This is a major difference from
what has been found in many malaria endemic
countries in Africa1,13,15 and may provide a good
basis for restricting the spread of drug resistance. A
majority of the private drug outlets in malaria
endemic areas in Sri Lanka were registered but most
of the vendors were not qualified pharmacists. They
had poor knowledge of the antimalarials. They
seemed unable to provide adequate advice to
customers buying antimalarials. However, these
private drug vendors appeared to be aware of the
importance of case confirmation before treatment and
hence their drug dispensing practices complied with
the malaria treatment guidelines. It may not be
surprising that the vendors did not know about SP
drugs since private drug outlets are not supposed to
sell Fansidar®. However, in the event it is decided
to make SP-based products available through private
outlets most likely as a response to increasing CQ
resistance, a significant programme will have to be
launched to educate the vendors as they have no prior
knowledge of these products.
In recent years Sri Lanka, as a whole, has experienced
very little malaria and this would have influenced
the knowledge and awareness of antimalarials,
treatment of malaria and related drug policies. The
age of the vendor was important when considering
the knowledge of antimalarials and the awareness
of the government malaria drug policy and could be
explained by the fact that vendors gained knowledge
through selling these drugs for long periods.
A WHO2 study group has shown that maintaining
the quality of the private service and compliance with
national malaria treatment guidelines are extremely
difficult due to influence from patient demand, drug
advertising and profit margins. According to the
available information from this study, drug
advertising and profit margins cannot be considered
as factors influencing the services of the private drug
vendors in Sri Lanka. None of the outlets had
displayed posters of antimalarials and no other media
provided information about the antimalarials in Sri
Lanka. Since the reported cases for the past few years
were extremely low compared to other highly
endemic countries and also considering the low cost
of a tablet, selling antimalarials is not very profitable
for vendors. Many outlets had stopped selling
antimalarials and out of the 113 drug outlets visited
in this study antimalarials were not available in 49
(43%) outlets. Also some vendors claimed that
misuse of CQ by pregnant women trying to provoke
abortions had made them stop selling antimalarials
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from this study showed that private drug vendors
were aware of the importance of case confirmation
before issuing antimalarial drugs. Therefore,
compared to the other malaria endemic countries,
there is a better private sector service in dispensing
antimalarials in Sri Lanka. Nevertheless, it is
important to mention here that vendor claimed in an
interview may not fully reflect his/her practice.
The seven districts of the study area were selected in
anticipation of possible differences in knowledge and
compliance with recommended treatment regimens
in the different regions of the country with a diversity
in transmission levels and differences in level of
armed conflict. However, no significant differences
in the knowledge or practices of the vendors in the
different areas were observed. Moreover, if the
survey had been done ten years ago when malaria
prevalence in the country was very high, the results
would have certainly been different.
Asymptomatic infections of P. falciparum and P.
vivax and dormant stages of  P. vivax normally
provide the parasite reservoir. Thus, low levels of
malaria in the recent past does not guarantee that
localised or even island-wide epidemics will not
occur16. It has been recorded in the past that even after
periods of very low levels of malaria transmission,
outbreaks have occurred, often following unusual
rainfall patterns, by constraints placed on the public
health system or by yet unexplained factors16.
Moreover, the low transmission levels over the past
years may also have made drug vendors less alert to
possible outbreaks. The preparedness and the capacity
of the private sector in handling a possible future
outbreak especially are thus important. This should be
specially targeted towards the younger vendors whose
knowledge on antimalarial treatment was poor. With
indications of rising prevalence of drug resistance
in the country3-6,8 attempts should be made to
integrate these vendors into government health care
education systems and attempt to improve the
services they can offer. Studies elsewhere have shown
that vendor-to-vendor education17 and training
wholesalers who can then, in turn, educate the
vendors could improve treatment by private drug
outlets. With the decentralisation of malaria control
activities, the education of private vendors can easily
be coupled with the national control activities at a
district level, so that the private vendors could be
groomed to be responsible service providers in the
treatment of malaria.
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